The pathophysiology and treatment of graft-versus-host disease
- 1 October 1983
- journal article
- review article
- Published by Elsevier in Clinics in Haematology
- Vol. 12 (3), 775-789
- https://doi.org/10.1016/s0308-2261(83)80010-1
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- U.S. Department of Health and Human Services
- American Cancer Society
This publication has 40 references indexed in Scilit:
- ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE INDUCED BY MINOR HISTOCOMPATIBILITY ANTIGENS IN MICETransplantation, 1983
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsNew England Journal of Medicine, 1983
- Prevention and Therapy of Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- EXPERIENCE WITH A COOPERATIVE BONE MARROW TRANSPLANTATION PROGRAM IN STOCKHOLMTransplantation, 1982
- A Randomized Study of the Prevention of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- FAILURE OF EARLY ADMINISTRATION OF ANTITHYMOCYTE GLOBULIN TO LESSEN GRAFT-VERSUS-HOST DISEASE IN HUMAN ALLOGENEIC MARROW TRANSPLANT RECIPIENTSTransplantation, 1981
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- ANTIHUMAN THYMOCYTE GLOBULIN FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASETransplantation, 1979